Companies providing instructions for 3D printed medical devices and drugs and companies printing them face potential liability. As part of our focus on emerging technology...
We have reported on the FDA’s recent statements regarding devices used for “vaginal rejuvenation” when the Food And Drug Administration first issued its warning and...
FDA Commissioner’s warning regarding deceptive health claims and significant risks related to devices marketed for use in medical procedures for “vaginal rejuvenation” raises significant concerns....
The United States Judicial Panel on Multidistrict Litigation just order that an MDL be formed. It is transferring Davol/Bard hernia mesh cases to the Southern...
As a reminder from our last post, one of the active hip litigations right now is BHR. Plaintiffs have asserted product liability claims against Smith...
In a July 30, 2018 Safety Communication , the FDA warned women considering elective vaginal “rejuvenation” procedures (and the health care providers who perform these...
We have an update from the MDL (multidistrict litigation) regarding recent decisions and activities. Of the 120,000 cases filed, 5,000 remain unsettled. The Judge is...
We recently updated you about Bayer's recent market withdrawal. There's been a recent court decision that provides another set back for the company. This time...
